Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Termeer Touts Campath-Linked CVRs
InVivo
Saturday, November 27, 2010 - 12:59pm
tags:
Henri Termeer, Campath, MS, Genzyme, multiple sclerosis, Sanofi
A $58M Loss: A Pfizer Prempro Appeal Is Denied
Pharmalot
Saturday, November 27, 2010 - 12:57pm
tags:
Pfizer, Wyeth, HRT, Prempro, appeals
Can Genzyme Make $3.5B a Year Giving Away a Drug for Free?
BNET Pharma
Saturday, November 27, 2010 - 12:53pm
tags:
Genzyme, alemtuzumab, Sanofi, MS, multiple sclerosis
Don't Get Too Worked Up Over Gilead's Earnings
Motley Fool
Saturday, November 27, 2010 - 12:33pm
tags:
Gilead Sciences, earnings
Virgin Market for New Bone Marrow Cancer Drug
Minyanville
Saturday, November 27, 2010 - 12:32pm
tags:
Incyte, myelofibrosis, YM BioSciences, CYT387, ONYX Pharmaceuticals
Sanofi leads drug stocks south
MarketWatch
Saturday, November 27, 2010 - 12:29pm
tags:
Sanofi
Genzyme open to Campath clause in Sanofi bid: report
Yahoo/Reuters
Saturday, November 27, 2010 - 12:28pm
tags:
Genzyme, Sanofi, M&A
Genzyme Lists Poison Pills, Talks to Other Companies, Termeer Tells Figaro
Bloomberg
Saturday, November 27, 2010 - 12:26pm
tags:
M&A, Genzyme, Sanofi
Sanofi Buyout Target Genzyme Meets First Deadline on Manufacturing Changes
Bloomberg
Wednesday, November 24, 2010 - 10:05am
tags:
M&A, Genzyme, Sanofi
Is Merck the Perfect Stock?
Motley Fool
Wednesday, November 24, 2010 - 8:34am
tags:
Merck
Twin blows spur a crisis of confidence in RNAi
Fierce Biotech
Wednesday, November 24, 2010 - 8:29am
tags:
RNAi, Roche, Alnylam
Patience With Bristol-Myers Squibb
Traders Huddle
Wednesday, November 24, 2010 - 8:18am
tags:
Bristol-Myers Squibb
'Record' drug shortages include cancer meds
Fierce Pharma
Wednesday, November 24, 2010 - 8:14am
tags:
drug shortages
Ligand Pharma says Roche terminates agreement
Reuters
Wednesday, November 24, 2010 - 8:13am
tags:
Roche, Ligand, hepatitis C
Abbott India Advances, Solvay Pharma Tumbles on Merger Plan
Bloomberg
Wednesday, November 24, 2010 - 7:59am
tags:
Abbott Laboratories, India, Solvay, M&A
Lilly, Acrux get FDA OK for topical testosterone
Marketwatch
Wednesday, November 24, 2010 - 7:58am
tags:
Acrux, Eli Lilly, FDA, testosterone, Axiron
Vt. law on drug data mining ruled unconstitutional
Yahoo/AP
Tuesday, November 23, 2010 - 10:06pm
tags:
data mining, Vermont
Positive Data on Alexion's Soliris
Yahoo/Zacks.com
Tuesday, November 23, 2010 - 10:05pm
tags:
Soliris, Alexion, aHUS, atypical hemolytic uremic syndrome
[video] Sell Pfizer!: Against the Grain
TheStreet.com
Tuesday, November 23, 2010 - 10:03pm
tags:
Pfizer
Novartis CEO Denies Layoff Rumors, Staff Still Worried
BNET Pharma
Tuesday, November 23, 2010 - 2:19pm
tags:
Novartis, cafepharma, layoffs, Joe Jimenez

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.